Promotion of cell growth and adhesion of a peptide hydrogel scaffold via mTOR/cadherin signaling

J Cell Physiol. 2018 Feb;233(2):822-829. doi: 10.1002/jcp.25864. Epub 2017 Apr 27.

Abstract

Understanding neurite outgrowth, orientation, and migration is important for the design of biomaterials that interface with the neural tissue. However, the molecular signaling alternations have not been well elucidated to explain the impact of hydrogels on cell morphology. In our previous studies, a silk fibroin peptide (SF16) hydrogel was found to be an effective matrix for the viability, morphology, and proliferation of PC12 rat pheocrhomocytoma cells. We found that PC12 cells in the peptide hydrogel exhibited adhesive morphology compared to those cultured in agarose or collagen. Moreover, we identified that cell adhesion molecules (E- and N-cadherin) controlled by mTOR signaling were highly induced in PC12 cells cultured in the SF16 peptide hydrogel. Our findings suggest that the SF16 peptide might be suitable to be a cell-adhesion material in cell culture or tissue engineering, and mTOR/cadherin signaling is required for the cell adhesion in the SF16-peptide hydrogel.

Keywords: PC12 cells; SF16 peptide; cadherin; hydrogel; mTOR.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Cadherins / metabolism*
  • Cell Adhesion* / drug effects
  • Cell Proliferation* / drug effects
  • Cell Shape
  • Fibroins / metabolism*
  • Hydrogels
  • Nerve Tissue Proteins / metabolism*
  • Neurons / drug effects
  • Neurons / enzymology*
  • PC12 Cells
  • Peptides / metabolism*
  • Protein Kinase Inhibitors / pharmacology
  • Rats
  • Signal Transduction
  • Sirolimus / pharmacology
  • TOR Serine-Threonine Kinases / antagonists & inhibitors
  • TOR Serine-Threonine Kinases / metabolism*
  • Tissue Scaffolds*

Substances

  • CDH1 protein, rat
  • Cadherins
  • Hydrogels
  • N-cadherin, rat
  • Nerve Tissue Proteins
  • Peptides
  • Protein Kinase Inhibitors
  • fibroin, silkworm
  • Fibroins
  • mTOR protein, rat
  • TOR Serine-Threonine Kinases
  • Sirolimus